felis - Articles
Pheochromocytoma
Introduction
- Very rare tumors.
- Tumors derived from chromaffin cells in adrenal medulla; occasionally extra-adrenal (paraganglioma).
- Signs: often vague - intermittent tachycardia, hypertension. May be an incidental finding during post-mortem examination or imaging.
- Diagnosis: radiography/CT scan/ultrasound, blood pressure measurements, eye fundus examination, normetanephrine concentration in plasma.
- Treatment: surgery, medical for hypertension.
- Prognosis: data is lacking to advise re prognosis statistics, but likely to be good if surgery is successful, no metastases and concurrent illness treated.
Presenting signs
- Intermittent collapse.
- Weakness.
- Anorexia.
- Vomiting/diarrhea.
- Restlessness.
- PUPD.
Acute presentation
- Theoretically sudden death due to cardiac arrhythmia Heart: dysrhythmia.
Age predisposition
- Old (>11 years).
Special risks
- Anesthesia and surgery as changes in blood flow on induction or trauma can → stimulation of catecholamine release → hypertension Hypertension and cardiac arrhythmias Heart: dysrhythmia.
Pathogenesis
Predisposing factors
General
- Chromaffin cell adrenal tumor or may be derived from extra-adrenal paraganglionic tissue.
- Secrete catecholamines (80% noradrenaline) which → vasoconstriction and hypertension by action on alpha and beta receptors → signs.
- Release often intermittent (may be mediated by changes in tumor blood flow and trauma → intermittent signs.
- May be malignant; if so, may invade caudal vena cava or metastasize to lung, liver or bone.
- Occasional incidental post-mortem finding.
Pathophysiology
- Signs related to release of catecholamines.
- Secretion of catecholamines is often intermittent and so signs are correspondingly variable and range from subclinical to cardiovascular collapse.
- Signs are related to secretion of catecholamines and their systemic effects:
- Generalized vasoconstriction by stimulation of alpha receptors.
- Positive chronotropic and inotropic effects on the heart.
- Capillary dilation and reduced gastrointestinal motility caused by stimulation of ß2 receptors.
Timecourse
- Weeks to years.
Diagnosis
Subscribe To View
This article is available to subscribers.
Try a free trial today or contact us for more information.
Treatment
Subscribe To View
This article is available to subscribers.
Try a free trial today or contact us for more information.
Outcomes
Subscribe To View
This article is available to subscribers.
Try a free trial today or contact us for more information.
Further Reading
Publications
Refereed papers
- Recent references from PubMed and VetMedResource.
- Prego M T, Dias M J, Ferreira R L et al (2023) Plasma and urinary metanephrine and normetanephrine concentrations using liquid chromatography with tandem mass spectrometry in healthy cats and in a cat with pheochromocytoma. J Vet Int Med 37 (3), 910-914 PubMed.
- Prego M T, Dias M J, Mestrinho L et al (2023) Diagnosis, treatment and outcome of pheochromocytoma in a cat. JSAP 64 (6), 415-420 PubMed.
- Daniel G, Mahony O M, Markovich J E et al (2015) Clinical findings, diagnostic and outcome in 33 cats with adrenal neoplasia (2002-2013). J Feline Med Surg 18 (2), 77-84 PubMed.
- Wimpole J A, Adagra C, Foster D J et al (2010) Plasma free metanephrines in healthy cats, cats with non-adrenal disease and a cat with suspected phaeochromocytoma. J Fel Med Surg 12 (6), 435-440 PubMed.
- Chun R, Jakovijevic S, Morrison W B et al (1998) Apocrine gland adenocarcinoma and pheochromocytoma in a cat. JAAHA 33 (1), 33-36 PubMed.
- Maher E R Jr. (1994) Pheochromocytoma in the dog and cat - diagnosis and management. Sem Vet Surg (Small Animal) 9 (3), 158-166 PubMed.
- Henry C J, Brewer W G Jr, Montgomery R D et al (1993) Clinical vignette. Adrenal Pheochromocytoma. JVIM 7 (3), 199-201 PubMed.
- Patnaik A K, Erlandson R A, Lieberman P H et al (1990) Extra-adrenal pheochromocytoma (paraganglioma) in a cat. JAVMA 197 (1), 104-106 PubMed.